Sai生命科学扩大了印度的制造能力,为全球市场促进了API生产。 Sai Life Sciences expands manufacturing capacity in India, boosting API production for global markets.

Sai生命科学已完成其在印度比达尔的API制造设施第11生产区第二阶段的工作,将其总反应堆能力提高到700千立升。 Sai Life Sciences has completed Phase II of its Production Block 11 at its API manufacturing facility in Bidar, India, increasing its total reactor capacity to 700 KL. 这一扩展为美国、欧盟和日本等高度管制市场的客户增加了可靠性和可扩展性。 This expansion adds reliability and scalability for clients in highly regulated markets, including the US, EU, and Japan. 该公司专门从事APIs,在全球雇用了3,400多名专业人员。 The company specializes in APIs and employs over 3,400 professionals globally.